Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$11.85 - $15.47 $273,735 - $357,357
23,100 New
23,100 $339,000
Q1 2024

May 15, 2024

SELL
$14.37 - $16.46 $1.98 Million - $2.26 Million
-137,600 Reduced 90.95%
13,700 $223,000
Q4 2023

Feb 14, 2024

SELL
$8.6 - $14.94 $1.3 Million - $2.26 Million
-151,500 Reduced 50.03%
151,300 $2.25 Million
Q3 2023

Nov 14, 2023

SELL
$9.81 - $12.62 $2.29 Million - $2.95 Million
-233,600 Reduced 43.55%
302,800 $3.4 Million
Q2 2023

Aug 14, 2023

BUY
$8.08 - $10.37 $1.28 Million - $1.64 Million
158,500 Added 41.94%
536,400 $5.4 Million
Q1 2023

May 15, 2023

BUY
$8.79 - $14.58 $2.43 Million - $4.03 Million
276,200 Added 271.58%
377,900 $3.55 Million
Q4 2022

Feb 13, 2023

BUY
$11.49 - $13.65 $1.17 Million - $1.39 Million
101,700 New
101,700 $1.24 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.